Charles Schoch Biography and Net Worth

Charles Schoch serves as Chief Financial Officer at Candel Therapeutics. He served as our Interim Chief Financial Officer from January 2024 to June 2025. Mr. Schoch joined the Candel in November 2021 and has served in various financial reporting and accounting positions of increasing responsibility, most recently as VP of Finance and Corporate Controller. During his time at Candel, Mr. Schoch built a high performing finance function that oversees Candel’s financial close process, internal controls, SEC reporting, financial planning, procurement, payroll, and treasury operations. Mr. Schoch has also worked closely with Candel’s executive leadership team on investor relations, business development, and financing initiatives. From 2019 to 2021, Mr. Schoch held the position of Corporate Controller at Corbus Pharmaceuticals. Before Corbus, he spent seven years in PwC’s Health Industry assurance practice where he served a diverse group of audit clients, ranging from pre-IPO to multinational public companies within the life sciences sector. Earlier in his career, Mr. Schoch worked for several Third Rock Venture portfolio companies as a financial and operational consultant.

Mr. Schoch holds an M.B.A. and M.S.A. from Northeastern University and a B.S. in Business Administration with a concentration in Finance from Elon University.